BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34935223)

  • 1. Early Welsh cervical screening programme learning as a consequence of the coronavirus pandemic.
    Leeson S; Evered A; Powell G; Lilly K; Singh N; Hillier S; Dunk L
    Cytopathology; 2022 May; 33(3):350-356. PubMed ID: 34935223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technological advances: Have they improved standards? Review of outcomes from the Welsh cervical screening programme.
    Castanon A
    J Med Screen; 2021 Jun; 28(2):80-87. PubMed ID: 32299280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a national cervical screening programme in Ireland, CervicalCheck: the first 6 years.
    Flannelly GM; Mooney MT; Greehy GM; Keogh EB; McNally SA; Fitzpatrick PE
    Eur J Cancer Prev; 2018 Mar; 27(2):158-163. PubMed ID: 27824660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
    Bokan T; Ivanus U; Jerman T; Takac I; Arko D
    Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the reported data of national rural cervical cancer screening project from 2012 to 2013, China].
    Luo XM; Song L; Wu JL; Liu Y; Di JL; Song B; Zheng RM; Ma L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):346-50. PubMed ID: 27029367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colposcopy for cervical screening in low-resource settings.
    de Sanjose S
    Lancet Glob Health; 2023 Mar; 11(3):e304-e305. PubMed ID: 36796965
    [No Abstract]   [Full Text] [Related]  

  • 10. HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study.
    Palmer TJ; McFadden M; Pollock KG; Kavanagh K; Cuschieri K; Cruickshank M; Cotton S; Nicoll S; Robertson C
    Br J Cancer; 2016 Mar; 114(5):582-9. PubMed ID: 26931370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of diagnostic indicators of cervical cancer screening among women accessing through volunteer organisations and those via the organised programme in Turin (Piedmont Region, Northern Italy).
    Ferrante G; Castagno R; Rizzolo R; Armaroli P; Caprioglio A; Larato C; Giordano L
    Epidemiol Prev; 2020; 44(5-6 Suppl 1):115-123. PubMed ID: 33415954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
    Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M
    Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
    Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X
    J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical pap smears and pandemics: The effect of COVID-19 on screening uptake & opportunities to improve.
    Masson H
    Womens Health (Lond); 2021; 17():17455065211017070. PubMed ID: 34032158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical Screening and Colposcopy Management of Women Age 24 and Under.
    Buick C; Jembere N; Wang L; Kupets R
    J Obstet Gynaecol Can; 2020 Dec; 42(12):1518-1524. PubMed ID: 32988802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV detection-based cervical cancer screening program in low-resource setting: lessons learnt from a community-based demonstration project in India.
    Mittal S; Mandal R; Banerjee D; Das P; Ghosh I; Panda C; Biswas J; Basu P
    Cancer Causes Control; 2016 Mar; 27(3):351-8. PubMed ID: 26712612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Cervical Dysplasia After Colposcopy Care and Risk-Informed Return to Population-Based Screening: A Systematic Review.
    Costa-Fagbemi M; Yakubu M; Meggetto O; Moffatt J; Walker MJ; Koné AP; Murphy KJ; Kupets R
    J Obstet Gynaecol Can; 2020 May; 42(5):607-624. PubMed ID: 31679914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic.
    Ciavattini A; Delli Carpini G; Giannella L; Arbyn M; Kyrgiou M; Joura EA; Sehouli J; Carcopino X; Redman CW; Nieminen P; Cruickshank M; Gultekin M
    Int J Gynecol Cancer; 2020 Aug; 30(8):1097-1100. PubMed ID: 32487685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.